Entry |
|
Name |
Adavosertib (USAN) |
Formula |
C27H32N8O2
|
Exact mass |
500.2648
|
Mol weight |
500.60
|
Structure |

|
Efficacy |
Antineoplastic, WEE1 tyrosine kinase inhibitor |
Target |
|
Pathway |
|
Brite |
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
Other
WEE1
D11361 Adavosertib (USAN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 37
1 C8y C 21.5397 -16.5749
2 C8y C 21.5397 -17.9735
3 C8x C 20.3509 -18.6727
4 N5x N 19.0922 -17.9735
5 C8y C 19.0922 -16.5749
6 N5x N 20.3509 -15.8756
7 C8y C 22.8699 -18.4056
8 N4y N 23.6919 -17.2742
9 N4y N 22.8699 -16.1427
10 O5x O 23.2982 -19.7239
11 C1b C 25.1061 -17.2742
12 C2b C 25.8054 -18.4853
13 C2a C 27.2037 -18.4853
14 C8y C 23.2982 -14.8245
15 N5x N 24.6559 -14.5359
16 C8y C 25.0881 -13.2057
17 C8x C 24.1524 -12.1664
18 C8x C 22.7946 -12.4550
19 C8x C 22.3624 -13.7850
20 C1d C 26.4706 -12.9117
21 C1a C 27.4350 -13.9828
22 C1a C 26.8983 -11.5966
23 O1a O 27.8215 -12.5498
24 N1b N 17.8869 -15.8656
25 C8y C 16.6784 -16.5502
26 C8x C 15.4594 -15.8326
27 C8x C 14.2423 -16.5216
28 C8y C 14.3003 -17.9201
29 C8x C 15.4495 -18.6378
30 C8x C 16.6665 -17.9488
31 N1y N 13.0745 -18.6340
32 C1x C 11.8504 -17.9336
33 C1x C 10.6419 -18.6376
34 N1y N 10.6474 -20.0361
35 C1x C 11.8715 -20.7365
36 C1x C 13.0800 -20.0325
37 C1a C 9.4421 -20.7381
BOND 41
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 2 7 1
8 7 8 1
9 8 9 1
10 1 9 1
11 7 10 2
12 8 11 1
13 11 12 1
14 12 13 2
15 9 14 1
16 14 15 2
17 15 16 1
18 16 17 2
19 17 18 1
20 18 19 2
21 14 19 1
22 16 20 1
23 20 21 1
24 20 22 1
25 20 23 1
26 5 24 1
27 24 25 1
28 25 26 2
29 26 27 1
30 27 28 2
31 28 29 1
32 29 30 2
33 25 30 1
34 28 31 1
35 31 32 1
36 32 33 1
37 33 34 1
38 34 35 1
39 35 36 1
40 31 36 1
41 34 37 1
|